Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 20/20 | 0.58 |
| ▸ | F2 | P00734 | 7/20 | 0.58 |
| ▸ | PLAT | P00750 | 4/20 | 0.58 |
| ▸ | PROC | P04070 | 4/20 | 0.52 |
| ▸ | PLG | P00747 | 3/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL8029273 | 0.81 | F10 (0.89) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7542319 | 0.80 | F10 (0.54) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7383804 | 0.80 | F10 (0.54) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7383978 | 0.79 | F10 (0.55) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7541583 | 0.79 | F10 (0.73) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7219241 | 0.78 | CYP2A6 (0.42) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7383888 | 0.78 | F10 (0.61) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7484771 | 0.78 | F10 (0.65) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7484777 | 0.78 | F10 (0.65) | F10F2PLATPROCPLG | |
| Trifluoroacetic Acid SCHEMBL7474056 | 0.78 | F10 (0.68) | F10F2PLATPROCPLG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0944386-B1 | SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS | AVENTIS PHARMA INC (US) | 2002-09-18 | — | — | EP | claimed |